Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked?

Journal of Cellular Biochemistry

Volumn 118, Issue 11, 2017, Pages 3577-3585

  Rehman, Kanwal ^a   Akash, Muhammad Sajid Hamid ^b  

^a UNIVERSITY OF AGRICULTURE   (Pakistan)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

DIABETES MELLITUS; INSULIN RESISTANCE; LIPID PEROXIDATION; OXIDATIVE STRESS; PLASMA ANTI OXIDANTS

Indexed keywords

4 HYDROXYNONENAL; BIOLOGICAL MARKER; CATALASE; GLUTATHIONE; GLYCOSYLATED PROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPHAGY; DIABETIC COMPLICATION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPID PEROXIDATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85019982283     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.26097     Document Type: Article

References (87)

1. Akash M, Rehman K, Rasool F, Sethi A, Abrar M, Irshad A, Abid A, Murtaza G. 2011. Alternate therapy of type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae). J Medicinal Plants Res 5:6885–6889.
2. Akash MS, Rehman K, Chen S. 2013a. Goto-Kakizaki rats: Its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus. Curr Diabetes Rev 9:387–396.
3. Akash MSH, Rehman K, Chen S. 2013b. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 114:525–531.
4. Akash MSH, Rehman K, Chen S. 2014a. Effects of coffee on type 2 diabetes mellitus. Nutrition 30:755–763.
5. Akash MSH, Rehman K, Chen S. 2014b. Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus. Nutrition 30:1128–1137.
6. Akash MSH, Rehman K, Tariq M, Chen S. 2015. Zingiber officinale and type 2 diabetes mellitus: Evidence from experimental studies. Crit Rev Eukaryot Gene Expr 25:91–112.
7. Araujo FB, Barbosa DS, Hsin CY, Maranhao RC, Abdalla DS. 1995. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis 117:61–71.
8. Asfandiyarova N, Kolcheva N, Ryazantsev I, Ryazantsev V. 2006. Risk factors for stroke in type 2 diabetes mellitus. Diab Vasc Dis Res 3:57–60.
9. Asmat U, Abad K, Ismail K. 2016. Diabetes mellitus and oxidative stress—A concise review. Saudi Pharm J 24:547–553.
10. Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. 2005. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol 289:H228–H236.
11. Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, Pattou F, Kerr-Conte J, Chroboczek J, Lemarchand P, Halimi S. 1998. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41:1093–1100.
12. Bernard C, Berthault MF, Saulnier C, Ktorza A. 1999. Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J 13:1195–1205.
13. Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V. 2001. Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50:315–321.
14. Butterfield DA, Koppal T, Howard B, Subramaniam R, Hall N, Hensley K, Yatin S, Allen K, Aksenov M, Aksenova M. 1998. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-Butyl-α-phenylnitrone and vitamin Ea. Ann N Y Acad Sci 854:448–462.
15. Ceriello A. 2006. Oxidative stress and diabetes-associated complications. Endocr Pract 12 Suppl 1:60–62.
16. Ceriello A, Esposito K, Piconi L, Ihnat M, Thorpe J, Testa R, Bonfigli AR, Giugliano D. 2008. Glucose “peak” and glucose ”spike”: Impact on endothelial function and oxidative stress. Diabetes Res Clin Pract 82:262–267.
17. Ceriello A, Kumar S, Piconi L, Esposito K, Giugliano D. 2007. Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. Diabetes Care 30:649–654.
18. Chen H, Li X, Epstein PN. 2005. MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes 54:1437–1446.
19. Chen HJ, Lin WP, Chiu SD, Fan CH. 2014. Multistage mass spectrometric analysis of human hemoglobin glutathionylation: Correlation with cigarette smoking. Chem Res Toxicol 27:864–872.
20. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50:1771–1777.
21. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. 1999. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 99:224–229.
22. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. 1999. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202–226.
23. Demircan N, Gurel A, Armutcu F, Unalacak M, Aktunc E, Atmaca H. 2008. The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Med Sci Monit 14:Cr97–C101.
24. Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, Kawamori R, Fujitani Y, Watada H. 2008. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 8:325–332.
25. El-Missiry MA, El Gindy AM. 2000. Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds. Ann Nutr Metab 44:97–100.
26. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 2002. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622.
27. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1–8.
28. Ferri J, Martinez-Hervas S, Espinosa O, Fandos M, Pedro T, Real JT, Chaves FJ, Cerda C, Saez G, Ascaso JF. 2008. 8-oxo-7,8-dihydro-2'-deoxyguanosine as a marker of DNA oxidative stress in individuals with combined familiar hyperlipidemia. Med Clin (Barc) 131:1–4.
29. Ford ES, Mokdad AH, Giles WH, Brown DW. 2003. The metabolic syndrome and antioxidant concentrations: Findings from the Third National Health and Nutrition Examination Survey. Diabetes 52:2346–2352.
30. Fukai T, Ushio-Fukai M. 2011. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15:1583–1606.
31. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752–1761.
32. Garcia-Bailo B, El-Sohemy A, Haddad PS, Arora P, Benzaied F, Karmali M, Badawi A. 2011. Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: Modulation of inflammation and oxidative stress. Biologics 5:7–19.
33. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y. 2003. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52:453–462.
34. Ghezzi P. 2013. Protein glutathionylation in health and disease. Biochim Biophys Acta 1830:3165–3172.
35. Grankvist K, Marklund SL, Taljedal IB. 1981. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 199:393–398.
36. Harmon JS, Gleason CE, Tanaka Y, Oseid EA, Hunter-Berger KK, Robertson RP. 1999. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 48:1995–2000.
37. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D. 1996. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 76:663–669.
38. Hopps E, Noto D, Caimi G, Averna MR. 2010. A novel component of the metabolic syndrome: The oxidative stress. Nutr Metab Cardiovasc Dis 20:72–77.
39. Hunt JV, Smith CC, Wolff SP. 1990. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420–1424.
40. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y. 1999. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927–932.
41. Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V. 2000. Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism 49:532–536.
42. Jung HS, Chung KW, Won Kim J, Kim J, Komatsu M, Tanaka K, Nguyen YH, Kang TM, Yoon KH, Kim JW, Jeong YT, Han MS, Lee MK, Kim KW, Shin J, Lee MS. 2008. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 8:318–324.
43. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC. 2002. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277:30010–30018.
44. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, Brumell JH. 2007. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 56:930–939.
45. Kubisch HM, Wang J, Luche R, Carlson E, Bray TM, Epstein CJ, Phillips JP. 1994. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci USA 91:9956–9959.
46. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N. 2004. The role of autophagy during the early neonatal starvation period. Nature 432:1032–1036.
47. Levine B, Klionsky DJ. 2004. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 6:463–477.
48. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P. 2002. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442.
49. Maeda K, Yasunari K, Sato EF, Inoue M. 2005. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. Atherosclerosis 181:87–92.
50. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY. 2001. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50:69–76.
51. Mahboob M, Rahman MF, Grover P. 2005. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J 46:322–324.
52. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D. 2004. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18:3066–3077.
53. Maritim AC, Sanders RA, Watkins JB, III. 2003. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 17:24–38.
54. Martinez-Hervas S, Fandos M, Real JT, Espinosa O, Chaves FJ, Saez GT, Salvador A, Cerda C, Carmena R, Ascaso JF. 2008. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis 199:384–389.
55. Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, Lewis GF, Giacca A. 1999. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524–530.
56. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. 2012. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J 12:5–18.
57. McGarry JD, Dobbins RL. 1999. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128–138.
58. Mendola J, Wright JR, Jr., Lacy PE. 1989. Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitis. Diabetes 38:379–385.
59. Murakami K, Kondo T, Ohtsuka Y, Fujiwara Y, Shimada M, Kawakami Y. 1989. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38:753–758.
60. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, Shimizu S. 2009. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461:654–658.
61. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790.
62. Nowotny K, Jung T, Hohn A, Weber D, Grune T. 2015. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5:194–222.
63. Pasaoglu H, Sancak B, Bukan N. 2004. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med 203:211–218.
64. Patel H, Chen J, Das KC, Kavdia M. 2013. Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovasc Diabetol 12:142–146.
65. Perez-Matute P, Zulet MA, Martinez JA. 2009. Reactive species and diabetes: Counteracting oxidative stress to improve health. Curr Opin Pharmacol 9:771–779.
66. Phillips M, Cataneo RN, Cheema T, Greenberg J. 2004. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin Chim Acta 344:189–194.
67. Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F. 2002. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: Possible role of oxidative stress. Metabolism 51:1340–1347.
68. Poitout V. 2002. Lipid partitioning in the pancreatic β cell: Physiologic and pathophysiologic implications. Curr Opin Endocrinol Diabetes 9:152–159.
69. Rehman K, Akash MS. 2016. Mechanisms of inflammatory responses and development of insulin resistance: How are they interlinked? J Biomed Sci 23:87.
70. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. 2003. Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587.
71. Rosenson RS. 2005. HDL-C and the diabetic patient: Target for therapeutic intervention? Diabetes Res Clin Pract 68 Suppl 2:S36–S42.
72. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. 2002. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85–96.
73. Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK. 2001. Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24:733–737.
74. Sies H. 1999. Glutathione and its role in cellular functions. Free Radic Biol Med 27:916–921.
75. Soliman GZ. 2008. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J 49:129–136.
76. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ. 2008. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest 118:3378–3389.
77. Souza JM, Peluffo G, Radi R. 2008. Protein tyrosine nitration—functional alteration or just a biomarker? Free Radic Biol Med 45:357–366.
78. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. 1999. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96:10857–10862.
79. Tiedge M, Lortz S, Munday R, Lenzen S. 1998. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578–1585.
80. Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. 2013. Markers of oxidative stress during diabetes mellitus. J Biomark 2013:378790.
81. Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D, Isenovic ER. 2015. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci 52:70–85.
82. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84.
83. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. 2006. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) 14:2127–2131.
84. Wu JJ, Quijano C, Chen E, Liu H, Cao L, Fergusson MM, Rovira II, Gutkind S, Daniels MP, Komatsu M, Finkel T. 2009. Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging (Albany NY) 1:425–437.
85. Xu B, Moritz JT, Epstein PN. 1999. Overexpression of catalase provides partial protection to transgenic mouse beta cells. Free Radic Biol Med 27:830–837.
86. Yla-Herttuala S. 1999. Oxidized LDL and atherogenesis. Ann N Y Acad Sci 874:134–137.
87. Zhou YP, Grill VE. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870–876.